Serum total cholesterol, statins and cognition in non-demented elderly

Neurobiol Aging. 2009 Jun;30(6):1006-9. doi: 10.1016/j.neurobiolaging.2007.09.012. Epub 2007 Nov 19.

Abstract

Background: The association between serum total cholesterol (TC), lipid-lowering drugs and cognition in the elderly is currently controversial.

Objective: To investigate the relationship between TC, lipid-lowering drugs and cognitive functions in non-demented elderly.

Design and setting: Participants of the Cardiovascular risk factors, aging and dementia (CAIDE) study were derived from random, population-based samples previously studied in 1972, 1977, 1982 or 1987. Analyses are based on 1382 non-demented participants re-examined in 1998 after an average follow-up of 21 years.

Results: High midlife TC was associated with poorer late-life episodic memory and category fluency. TC decreased in most individuals over time. A more pronounced decrease was related to poorer late-life episodic memory and psychomotor speed, but not if subjects used statins.

Conclusions: The TC-cognition relationship seems bidirectional. High midlife TC is associated with poorer late-life cognition, but decreasing TC after midlife may reflect poorer cognitive status. Statins may be beneficial for cognition in non-demented elderly.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / blood*
  • Cholesterol / blood*
  • Cognition / physiology*
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / blood*
  • Male
  • Middle Aged
  • Statistics as Topic

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Cholesterol